N=90 Number of trials n (%) | |
---|---|
Long-term condition | 51 (56.7) |
Rare condition | 2 (2.2) |
Conditions expected to reduce lifespan | 27 (30.0) |
General shortening | 14/27 (51.9) |
Rapid mortality | 13/27 (48.2) |
Conditions under study* | |
Mental health | 15 (16.7) |
Heart disease/condition | 3 (3.3) |
Haematology/phlebology | 7 (7.8) |
Infections | 7 (7.8) |
Musculoskeletal | 6 (6.7) |
Cancer | 3 (3.3) |
Renal | 4 (4.4) |
Childbirth and pregnancy | 2 (2.2) |
Obstetrics and gynaecology | 2 (2.2) |
Addiction | 4 (4.4) |
Dermatology | 2 (2.2) |
Gastroenterology | 6 (6.7) |
Diabetes | 2 (2.2) |
Obesity/nutrition | 3 (3.3) |
Falls in the elderly | 3 (3.3) |
Sleep disorders | 2 (2.2) |
Stroke | 4 (4.4) |
Dental | 2 (2.2) |
Degenerative neurological disorders | 4 (4.4) |
Respiratory | 4 (4.4) |
Other | 5 (5.6) |
Aim of intervention | |
Treatment | 74 (82.2) |
Prevention | 13 (14.4) |
Diagnostic | 3 (3.3) |
Nature of interventions used* | |
Drug | 31 (34.4) |
Behavioural | 17 (18.9) |
Device | 15 (16.7) |
Surgery | 16 (17.8) |
Comparison with conservative management (n=16) | 7 (43.8) |
Physical, eg, exercise | 11 (12.2) |
Educational | 10 (11.1) |
Community care | 5 (5.6) |
Other | 4 (4.4) |
Commissioned brief† | 45 (50.0) |
*Categories not mutually exclusive.
†Topic of research identified by the funders for which collaborative applications are invited as opposed to an open call in which the applicants suggest the topic of research.